Bristol-Myers Squibb Co.
Income Statement
| Line Item | FY2009 | FY2008 | FY2007 | FY2006 |
|---|---|---|---|---|
| Revenue | $18.81B | $17.72B | $15.61B | $13.86B |
| United States | $11.05B | $10.48B | $9.19B | $8.10B |
| International | $7.76B | $7.23B | $6.42B | $5.77B |
| Cost of Revenue | $5.14B | $5.32B | $4.92B | — |
| Gross Profit | $13.67B | $12.40B | $10.69B | — |
| Gross Margin | 72.7% | 70.0% | 68.5% | — |
| Operating Expenses | ||||
| Research & Development | $3.65B | $3.51B | $3.16B | — |
| SG&A Expense | $3.95B | $4.14B | $3.94B | — |
| Operating Income | $5.79B | $5.09B | $2.52B | — |
| Operating Margin | 30.8% | 28.7% | 16.2% | — |
| Interest Expense | $184.0M | $310.0M | — | — |
| Pretax Income | $5.60B | $4.78B | $2.52B | — |
| Income Tax Expense | $1.18B | $1.09B | $471.0M | — |
| Net Income | $10.61B | $5.25B | $2.17B | — |
| Net Margin | 56.4% | 29.6% | 13.9% | — |
| EPS (Basic) | $5.35 | $2.64 | $1.09 | — |
| EPS (Diluted) | $5.34 | $2.62 | $1.09 | — |
| Shares Outstanding (Basic) | 1.97B | — | — | — |
| Shares Outstanding (Diluted) | 1.98B | — | — | — |
| Dividends Per Share | $1.25 | $1.24 | $1.15 | — |